How methamphetamine affects HIV in stable patients
Part of Infections clinical trials.
This study gives HIV-positive people who are doing well on HIV medication a small dose of methamphetamine to see how it affects their virus and immune system. Researchers want to understand if methamphetamine can wake up hidden HIV that's not being detected.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have HIV and have been on the same HIV medications for at least 12 months with no changes in the last 3 months
- Your HIV viral load has been undetectable (below 40 copies/ml) for at least 12 months
- You have no history of methamphetamine addiction or abuse
- You are willing to use two forms of birth control for 4–5 months and up to 2 months after the study ends
- You are between 18 and 65 years old and available for the full 4–5 month study period
- You do not have serious heart problems, uncontrolled high blood pressure, seizures, or recent psychiatric symptoms like hallucinations
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a drug called psilocybin (a psychedelic) can help people with HIV stop using methamphetamine. If you want to quit meth and are living with HIV, this trial might offer a new approach.
This study tests a smartphone program to help HIV-negative men who have sex with men reduce meth use and improve PrEP adherence. It explores whether combining support for both behaviors is more effective than addressing them separately.
This study tests whether a medication called 'Glutide' (a GLP-1 agonist, similar to drugs used for diabetes) can help people who want to stop or cut down on methamphetamine. It's for those with moderate to severe meth use disorder who have used meth on at least 15 of the past 30 days.
This study tests if a long-acting HIV treatment shot, called Cabenuva, works well for people who use drugs like methamphetamine or GHB during sex. It may help make treatment easier for those who find daily pills challenging.
This trial tests a single dose of an investigational drug, CS-1103, to see if it is safe and effective for people who use methamphetamine. It may help understand how the drug affects methamphetamine in the body.
This study looks at how meth use risk and experiences of stigma may affect HIV prevention needs for HIV-negative Latino/Hispanic men. If you qualify, you may be asked about your substance use, recent sexual activity, and stigma experiences to help improve prevention support.
Hear when a new HIV-1-infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.